Harvard's Christine Seidman to receive 2019 Vanderbilt Prize in Biomedical Science
Christine Seidman, MD, whose lab has identified the genetic causes of several human heart diseases including cardiomyopathy (potentially fatal enlargement of the heart), is the recipient of the 2019 Vanderbilt Prize in Biomedical Science. View...
Robin Steaban: Culture Survey ensures leaders hear from everyone
The first in a series of Q&A interviews with leaders to talk about why all employees should take the Culture Survey: Pulse Edition, May 1-15 View...
A VUMC-led team took on a challenge to develop a Zika virus treatment in 90 days. They finished 12 days early.
In January scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis were given an audacious goal to develop -- in 90 days -- a protective antibody-based treatment that potentially will stop the spread of the Zika virus. They finished on April 2 --12 days early. View...
How do cancer biomarkers get into the bloodstream? Not the way we thought.
A report by researchers at Vanderbilt University Medical Center has shattered conventional wisdom about how cells, including cancer cells, shed DNA into the bloodstream. View...
Celebrate Diversity Month at tomorrow's multicultural fair on the Plaza
Representatives from several of Nashville's multicultural organizations will be on hand to share information about the city's ethnic communities and how employees can get involved. View...
Biomedical Research Awareness Day features lecture on organ recovery and transplantation, April 18
The Biomedical Research Awareness Day lecture by Matthew Bacchetta will be April 18 at 12:15 p.m. in 208 Light Hall. View...
VUMC in the news
A roundup of a few recent stories from the press about Vanderbilt University Medical Center. View...

